Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (241-250 of 494) with videos related to

Pageof 50
Sort By:
Cancer Management and Research|December 7, 2018
Upregulation of centromere protein F is linked to aggressive prostate cancersCosima Göbel, Cansu Özden, Cornelia Schroeder, et al.
Cancer Research|October 9, 2013
Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signalingYi Qu, Anne Margrete Oyan, Runhui Liu, et al.
Experimental and Molecular Pathology|August 17, 2013
Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomyKatharina Grupp, Thorsten Simon Höhne, Kristina Prien, et al.
Histopathology|September 16, 2010
Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosisAndreas H Marx, Margarete Zielinski, Charlotte-Marie Kowitz, et al.
Molecular Carcinogenesis|May 4, 2017
Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusionManuela Juhnke, Asmus Heumann, Viktoria Chirico, et al.
Molecular and Clinical Oncology|August 31, 2021
High mitochondrial content is associated with breast cancer aggressivenessPatrick Lebok, Katharina Schütt, Martina Kluth, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 18, 2004
Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancerRobert Stoehr, Christoph Wissmann, Hiromu Suzuki, et al.
Journal of Clinical Pathology|August 3, 2006
HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancerKhawla Al-Kuraya, Hedvika Novotny, Prashant Bavi, et al.
BMC Cancer|November 14, 2018
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcomeKatharina Grupp, Bianca Hofmann, Asad Kutup, et al.
International Journal of Cancer|May 27, 2015
Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancerMartina Kluth, Frederic Runte, Philipp Barow, et al.
Pageof 50

Showing results (241-250 of 494) with videos related to

Sort By:
Pageof 50
Cancer Management and Research|December 7, 2018
Upregulation of centromere protein F is linked to aggressive prostate cancersCosima Göbel, Cansu Özden, Cornelia Schroeder, et al.
Cancer Research|October 9, 2013
Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signalingYi Qu, Anne Margrete Oyan, Runhui Liu, et al.
Experimental and Molecular Pathology|August 17, 2013
Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomyKatharina Grupp, Thorsten Simon Höhne, Kristina Prien, et al.
Histopathology|September 16, 2010
Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosisAndreas H Marx, Margarete Zielinski, Charlotte-Marie Kowitz, et al.
Molecular Carcinogenesis|May 4, 2017
Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusionManuela Juhnke, Asmus Heumann, Viktoria Chirico, et al.
Molecular and Clinical Oncology|August 31, 2021
High mitochondrial content is associated with breast cancer aggressivenessPatrick Lebok, Katharina Schütt, Martina Kluth, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 18, 2004
Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancerRobert Stoehr, Christoph Wissmann, Hiromu Suzuki, et al.
Journal of Clinical Pathology|August 3, 2006
HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancerKhawla Al-Kuraya, Hedvika Novotny, Prashant Bavi, et al.
BMC Cancer|November 14, 2018
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcomeKatharina Grupp, Bianca Hofmann, Asad Kutup, et al.
International Journal of Cancer|May 27, 2015
Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancerMartina Kluth, Frederic Runte, Philipp Barow, et al.
Pageof 50